Two days in, and the MedTech World Asia 2026 summit showed no signs of slowing down. Day 1 had set a high bar: cross-border MoU signings, government keynotes, eight company showcases, and no shortage of frank talk about capital. But today belonged to the finale everyone had been waiting for. Doors opened once more at the Hong Kong Convention and Exhibition Centre for a final round of panels and showcases, all building toward the one fixture circled on nearly every delegate’s agenda: the MedTech World Startup Pitch Competition.
The exhibition floor and Startup Village remained lively through to the closing bell, with delegates moving between booths for one last look at the innovations on display. The fourth edition of MedTech World Magazine, officially launched during the conference, was also circulating around the venue, giving attendees a first glimpse of the latest issue. Over in the 1:1 matchmaking room, founders, investors, and partners kept the schedule full late into the afternoon, squeezing in a final round of introductions before the summit wrapped.
From the Greater Bay Area to the capital stack
The day opened with the panel The Greater Bay Area Advantage: Building MedTech at the HK–China Intersection, which unpacked how GBA policy, Shenzhen’s manufacturing base, and Hong Kong’s regulatory gateway combine to create a launchpad for MedTech companies with global ambitions. That was followed by a keynote on The New Obesity Paradigm: Drugs, Devices, Data and Policy, making the case that sustainable obesity management will take an integrated ecosystem of medicine, technology, behaviour, and policy rather than any single drug or device.
The capital conversation picked up with From Series A to IPO: Navigating the Asian Capital Stack, where investors walked through the milestones and metrics that move a MedTech company toward a credible path to public markets in Asia.
Four more companies take the stage
Day 2 brought its own round of company showcases, giving four more founders and CEOs the Main Stage spotlight to make their case to a room of investors, hospital leaders, and partners:
- Lindo Technology Group
- Tresquare Technologies
- Gero
- UBTECH Robotics
The showcases were followed by a session on Advancing the Da Vinci Ecosystem in China, before the agenda turned to Building for Half the Market: Clinical and Commercial Strategies in Women’s Health.
State of HealthTech 2026
One of the day’s standout sessions came from Verge HealthTech Fund, whose leadership took to the Main Stage to present “State of HealthTech 2026.” The presentation offered delegates a data-driven view of where HealthTech investment, innovation, and adoption stand across the region heading into the second half of 2026, providing a fitting complement to the funding and capital conversations that ran throughout both days of the summit.
From there, the agenda moved to the panel From Pitch to Scale: What Makes MedTech Startups Win in Asia, examining what separates funded startups from those that truly scale.
An invite-only look at cross-border exits
Away from the Main Stage, one of the day’s true highlights unfolded behind closed doors. An invite-only luncheon, “Cross-Border Exit Architecture for Asian MedTech Companies,” powered by CFGI, brought together senior investors, founders, and finance leaders to discuss deal structuring, tax and entity architecture, and what it actually takes to close a clean cross-border exit as Asian MedTech companies scale toward liquidity events, dual-track M&A, and IPO readiness.
Robotics, market access, and the road to the pitch
The afternoon continued with Beyond VC: Strategic Partnerships, Corporate Venture, and Alternative Funding Models, followed by The Next Generation of Medical Robotics in Asia, which examined surgical platforms, robotic bronchoscopy, and next-generation minimally invasive systems across the region. This was followed by the panel India as a MedTech Powerhouse: Manufacturing, Innovation & Market Access, rounding out the day’s exploration of where the next wave of growth is coming from. And then a short presentation from Pegasus Tech Ventures.
The headliner: MedTech World Startup Pitch Competition
Then came the moment two days of showcases, funding conversations, and cross-border dealmaking had been building toward: the MedTech World Startup Pitch Competition, co-hosted this year with Startup World Cup and powered by Ascend CRO, Blue Goat Cyber, and Malta Enterprise.
Ten finalists, selected from a highly competitive global applicant pool, took to the Main Stage to pitch solutions spanning AI-driven elder and pet health monitoring, needle-free biosensing, next-generation surgical robotics, and breakthrough organ preservation technology:
- Yinrunkang (Shenzhen) Technology Co., Ltd — Hu Huanzhi, Project Roadshow Lead
- LCM Biosensor Technologies — Ramil Musin, CEO
- Würzburg Dynamics (Shenzhen) Ltd — Shenghan Huang, Co-founder
- OnePass Medical — Jacob BenArie, Co-Founder and CEO
- Monarch Technologies — Lukas Hertle, Co-Founder
- Beijing Best HealthCare Technology Co., Ltd — Meng Ge, CEO
- Vascular Perfusion Solutions, Inc. (VPS) — Dr. Rafael Veraza, CEO & President
- Oculoo — Simon Terhurne, CEO & Co-Founder
- Rosalind Dx — Ella Fung, CEO & Co-Founder
- E-SENSE Innovation & Technology — Russell Chan, CEO & Co-Founder
It was a tough field to judge, and the panel had its work cut out. The finalists faced a distinguished bench of investors:
- David Frankenfield — Operating Partner, Braxton Capital Ventures
- Von Leong — Co-Founder, Purpose Venture Capital and Philanthropy
- Sahir Ali — Founder & General Partner, Modi Ventures
- Ken Nelson — Investor & Board Member, Nelson Jennings Ventures
- Varun Turalapati — Managing Director, Chaanakya Capital
- Kelly Qiao — Sr. Principal, B Capital
- Chen Daozhen — Founder & President, Panshi Chuanghui International Investment (Shenzhen) Co., Ltd.
- Laurent Pacheco — Managing Partner, International Family Office Alliance for Health
- Marcus Hui — Vice President, GT Healthcare Capital Partners
- Vinern Leow — Vice President, Ascend Capital Partners
After a closely fought round of pitches, Ella Fung, CEO & Co-Founder of Rosalind Dx, was named winner of the MedTech World Startup Pitch Competition Asia 2026, for the company’s accessible prenatal test that detects chromosomal abnormalities in pregnancy. Rosalind Dx’s dPCR-based kit runs five times faster. It is cheaper for labs than existing options, putting accurate prenatal screening within reach of more parents — building on a founding team that has previously developed more than ten US IVDs, including PerkinElmer’s prenatal test and Roche’s first liquid biopsy test.
Closing reception at the Waterfall Bar
As the Main Stage sessions and the pitch competition wrapped, delegates made their way to the Closing Reception at Grand Hyatt, Waterfall Bar, bringing MedTech World Asia 2026 | Hong Kong to a close over a complimentary drink, one last round of catch-ups, and reflections on two days of keynotes, showcases, capital conversations, and cross-border dealmaking.
From the opening MoU signings on Day 1 to a Startup Pitch winner crowned on Day 2, MedTech World’s inaugural Hong Kong summit delivered on its promise as a gateway between Asia’s MedTech ecosystem and the rest of the world.
Can’t make it to Hong Kong this year? Pre-register now for MedTech World Asia 2027 and be the first to know when tickets and details go live.
Next up: MedTech World Europe 2026 | Malta
The MedTech World story doesn’t stop in Hong Kong. From 11–13 November 2026, the community reconvenes in Valletta, Malta, for MedTech World Europe 2026 — the culmination of all of this year’s events and the home of MedTech World, with its biggest edition yet. The summit will welcome 2,000+ industry leaders, startups, and investors for three days of keynotes, company showcases, capital conversations, awards and recognitions, exclusive forums, and its own Startup Pitch Competition — and so much more.
Book your seat for MedTech World Europe 2026 | Malta before tickets are gone.
Source link
